Kimberly Struble

2.1k total citations
42 papers, 1.5k citations indexed

About

Kimberly Struble is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Kimberly Struble has authored 42 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Infectious Diseases, 21 papers in Virology and 9 papers in Epidemiology. Recurrent topics in Kimberly Struble's work include HIV/AIDS drug development and treatment (26 papers), HIV/AIDS Research and Interventions (21 papers) and HIV Research and Treatment (20 papers). Kimberly Struble is often cited by papers focused on HIV/AIDS drug development and treatment (26 papers), HIV/AIDS Research and Interventions (21 papers) and HIV Research and Treatment (20 papers). Kimberly Struble collaborates with scholars based in United States, South Africa and Thailand. Kimberly Struble's co-authors include Laura W. Cheever, Debra Birnkrant, Kirk M. Chan‐Tack, Jeffrey S. Murray, Lisa K. Naeger, Stephen C. Piscitelli, Roberta Black, Lisa A. Grohskopf, Ida M. Onorato and Michael Johnson and has published in prestigious journals such as Hepatology, Clinical Infectious Diseases and The American Journal of Medicine.

In The Last Decade

Kimberly Struble

41 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kimberly Struble United States 19 1.1k 555 546 201 164 42 1.5k
Fiona Mulcahy Ireland 23 1.1k 1.0× 428 0.8× 679 1.2× 287 1.4× 158 1.0× 48 2.1k
Kenneth Tapia United States 23 857 0.8× 495 0.9× 478 0.9× 141 0.7× 84 0.5× 57 1.3k
Melissa Krone United States 17 872 0.8× 566 1.0× 862 1.6× 287 1.4× 163 1.0× 25 1.7k
Christine Danel France 21 1.2k 1.1× 682 1.2× 683 1.3× 303 1.5× 71 0.4× 75 1.6k
Kristine B. Patterson United States 26 1.7k 1.6× 655 1.2× 1.0k 1.9× 308 1.5× 185 1.1× 60 2.2k
James Hellinger United States 19 1.4k 1.3× 741 1.3× 819 1.5× 329 1.6× 74 0.5× 30 1.8k
Mauro Zaccarelli Italy 25 1.2k 1.1× 498 0.9× 953 1.7× 218 1.1× 87 0.5× 91 1.7k
Ray Y. Chen United States 26 1.5k 1.4× 1.0k 1.8× 572 1.0× 197 1.0× 269 1.6× 44 1.9k
Zara Shubber United Kingdom 25 1.7k 1.5× 1.1k 2.0× 519 1.0× 270 1.3× 151 0.9× 46 2.1k
F Mulcahy Ireland 19 800 0.7× 594 1.1× 316 0.6× 159 0.8× 51 0.3× 66 1.4k

Countries citing papers authored by Kimberly Struble

Since Specialization
Citations

This map shows the geographic impact of Kimberly Struble's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kimberly Struble with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kimberly Struble more than expected).

Fields of papers citing papers by Kimberly Struble

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kimberly Struble. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kimberly Struble. The network helps show where Kimberly Struble may publish in the future.

Co-authorship network of co-authors of Kimberly Struble

This figure shows the co-authorship network connecting the top 25 collaborators of Kimberly Struble. A scholar is included among the top collaborators of Kimberly Struble based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kimberly Struble. Kimberly Struble is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Grimstein, Manuela, Hari Cheryl Sachs, Mark Mirochnick, et al.. (2021). Characterization of Plasma Protein Alterations in Pregnant and Postpartum Individuals Living With HIV to Support Physiologically-Based Pharmacokinetic Model Development. Frontiers in Pediatrics. 9. 721059–721059. 8 indexed citations
2.
Chan‐Tack, Kirk M., Patrick R. Harrington, Suyoung Choi, et al.. (2021). Benefit-risk assessment for brincidofovir for the treatment of smallpox: U.S. Food and Drug Administration's Evaluation. Antiviral Research. 195. 105182–105182. 55 indexed citations
3.
4.
Struble, Kimberly, et al.. (2019). Cobicistat-containing antiretroviral regimens are not recommended during pregnancy. AIDS. 33(6). 1089–1093. 25 indexed citations
5.
Kwong, Ann D., et al.. (2014). Accelerating Drug Development Through Collaboration: The Hepatitis C Drug Development Advisory Group. Clinical Pharmacology & Therapeutics. 96(2). 162–165. 9 indexed citations
6.
Kuhar, David T., David K. Henderson, Kimberly Struble, et al.. (2013). Updated US Public Health Service Guidelines for the Management of Occupational Exposures to Human Immunodeficiency Virus and Recommendations for Postexposure Prophylaxis. Infection Control and Hospital Epidemiology. 34(9). 875–892. 207 indexed citations
7.
Soon, Guoxing, Min Min, Kimberly Struble, et al.. (2012). Meta-Analysis of Gender Differences in Efficacy Outcomes for HIV-Positive Subjects in Randomized Controlled Clinical Trials of Antiretroviral Therapy (2000–2008). AIDS Patient Care and STDs. 26(8). 444–453. 56 indexed citations
8.
Mani, Nina, Jeffrey S. Murray, Roy M. Gulick, et al.. (2012). Novel clinical trial designs for the development of new antiretroviral agents. AIDS. 26(8). 899–907. 12 indexed citations
9.
Sorbello, Alfred, S. Christopher Jones, Kimberly Struble, et al.. (2012). Emergency Use Authorization for Intravenous Peramivir: Evaluation of Safety in the Treatment of Hospitalized Patients Infected With 2009 H1N1 Influenza A Virus. Clinical Infectious Diseases. 55(1). 1–7. 42 indexed citations
10.
Nelson, Robert M., Linda Lewis, Kimberly Struble, & Susan F. Wood. (2010). Ethical and Regulatory Considerations for the Inclusion of Adolescents in HIV Biomedical Prevention Research. JAIDS Journal of Acquired Immune Deficiency Syndromes. 54(Supplement 1). S18–S24. 58 indexed citations
11.
Naeger, Lisa K., Kimberly Struble, Jeffrey S. Murray, & Debra Birnkrant. (2009). Running a tightrope: Regulatory challenges in the development of antiretrovirals. Antiviral Research. 85(1). 232–240. 11 indexed citations
12.
Chan‐Tack, Kirk M., Kimberly Struble, & Debra Birnkrant. (2008). Intracranial Hemorrhage and Liver-Associated Deaths Associated with Tipranavir/Ritonavir: Review of Cases from the FDA's Adverse Event Reporting System. AIDS Patient Care and STDs. 22(11). 843–850. 24 indexed citations
13.
Struble, Kimberly, Kirk M. Chan‐Tack, & Guoxing Soon. (2008). Regulatory issues in developing new HIV protease inhibitors: risks and benefits. Current Opinion in HIV and AIDS. 3(6). 676–680. 2 indexed citations
14.
Chan‐Tack, Kirk M., et al.. (2008). Are Literature References Sufficient for Dose Recommendations? An FDA Case Study of Efavirenz and Rifampin. The Journal of Clinical Pharmacology. 48(4). 518–523. 9 indexed citations
15.
Chan‐Tack, Kirk M., Kimberly Struble, Jeffrey S. Murray, et al.. (2008). HIV clinical trial design for antiretroviral development: moving forward. AIDS. 22(18). 2419–2427. 14 indexed citations
16.
Chan‐Tack, Kirk M., et al.. (2007). Atazanavir-associated nephrolithiasis: cases from the US Food and Drug Administration's Adverse Event Reporting System. AIDS. 21(9). 1215–1218. 82 indexed citations
17.
Naeger, Lisa K. & Kimberly Struble. (2006). Effect of baseline protease genotype and phenotype on HIV response to atazanavir/ritonavir in treatment-experienced patients. AIDS. 20(6). 847–853. 36 indexed citations
18.
Naeger, Lisa K. & Kimberly Struble. (2006). Food and Drug Administration analysis of tipranavir clinical resistance in HIV-1-infected treatment-experienced patients. AIDS. 21(2). 179–185. 26 indexed citations
19.
Johann‐Liang, Rosemary, et al.. (2005). Reporting of Deaths During Pre-Approval Clinical Trials for Advanced HIV-Infected Populations. Drug Safety. 28(7). 559–564.
20.
Mann, Marianne, et al.. (1999). Unusual Distributions of Body Fat in AIDS Patients: A Review of Adverse Events Reported to the Food and Drug Administration. AIDS Patient Care and STDs. 13(5). 287–295. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fiona Mulcahy Breakdown of academic impact, for papers by Kenneth Tapia Breakdown of academic impact, for papers by Melissa Krone Breakdown of academic impact, for papers by Christine Danel Breakdown of academic impact, for papers by Kristine B. Patterson Breakdown of academic impact, for papers by James Hellinger Breakdown of academic impact, for papers by Mauro Zaccarelli Breakdown of academic impact, for papers by Ray Y. Chen Breakdown of academic impact, for papers by Zara Shubber Breakdown of academic impact, for papers by F Mulcahy
Rankless by CCL
2026